Clinical Trial Update: Secondary Sclerosing Cholangitis in Critically Ill Patients

View source ↗

Summary

The clinical trial NCT02545309 studying secondary sclerosing cholangitis in critically ill patients is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis in Critically Ill Patients

Snippet

Sponsor: Medical University of Graz | Conditions: Secondary Sclerosing Cholangitis | Status: ACTIVE_NOT_RECRUITING